Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-26 @ 8:51 PM
Study NCT ID:
NCT04672356
Status:
COMPLETED
Last Update Posted:
2023-06-22
First Post:
2020-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety , Tolerability and Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced Lung Cancer
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-13
First Submit QC Date:
None
Study First Post Date:
2020-12-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-18
Last Update Post Date:
2023-06-22
Last Update Post Date Type:
ACTUAL